|
WO2020168760A1
|
|
Use of albiflorin in preparation of drugs for rapidly treating depression
|
|
WO2020020343A1
|
|
Use of total glucosides of paeony as potentiating agent for immunological checkpoint inhibitor for tumor treatment
|
|
WO2020020342A1
|
|
Use of total glucosides of paeonia for preventing or treating diabetes
|
|
WO2018068566A1
|
|
Application of albiflorin in production of products for improving function of intestinal flora system
|
|
EP3566707A1
|
|
Application of albiflorin as indoleamine 2,3-dioxygenase (ido) inhibitor
|
|
CN107412244A
|
|
Purposes of the albiflorin in the product for improving epiphysin systemic-function is prepared
|
|
EP3263114A1
|
|
Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome
|
|
CN103179973A
|
|
Antianxiety and sleep disorder improving use of albiflorin or metabolite thereof in
|
|
US2013231469A1
|
|
Method for preparing albiflorin and paeoniflorin
|
|
CN102372750A
|
|
Method for simultaneously preparing albiflorin and paeoniflorin
|
|
US2010310682A1
|
|
Pharmaceutical compositions for treating anxiety
|
